0 Comentários
0 Compartilhamentos
690 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
- Faça Login para curtir, compartilhar e comentar!
- Beyond Injection: Exploring the Diverse Uses of Fluorouracil (5FU)Fluorouracil, often abbreviated as 5FU, is a cornerstone of cancer treatment. Its journey began in the 1950s, making it one of the oldest and most widely used chemotherapy medications. Traditionally administered through injection, 5FU has established itself as a formidable weapon in the fight against various cancers. However, the story of 5FU goes beyond the needle. Disrupting the Cell Cycle:...0 Comentários 0 Compartilhamentos 818 Visualizações 0 Anterior
- Driving the growth of Skin Barrier Products MarketThe global Skin Barrier Products Market is estimated to be valued at US$ 1063.94 Mn or Mn in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. SWOT Analysis: - · Strength: - Advanced wound care products offering properties like...0 Comentários 0 Compartilhamentos 1322 Visualizações 0 Anterior
- Harnessing the Power of Fluorouracil (5FU): Advances and Applications in Cancer TreatmentIn the arsenal of cancer-fighting medications, Fluorouracil, commonly known as 5FU, stands as a stalwart soldier. Its efficacy and versatility have made it a cornerstone in the treatment of various cancers. Understanding Fluorouracil (5FU): Fluorouracil is a chemotherapy medication that belongs to the class of antimetabolites. It works by interfering with the synthesis of DNA and RNA,...0 Comentários 0 Compartilhamentos 1034 Visualizações 0 Anterior
- Metastatic Melanoma Therapeutics: Advances in Treatment Options for Metastatic MelanomaWhile ipilimumab was an important first approval, it only helped about 15-20% of patients and many experienced severe side effects. Since then, several other immunotherapies have been approved that have higher response rates and are generally better tolerated. Keytruda (pembrolizumab) was approved in 2014 for metastatic melanoma patients whose cancer had stopped responding to other treatments....0 Comentários 0 Compartilhamentos 328 Visualizações 0 Anterior
- Oncology is the largest segment driving the growth of Skin Cancer Drugs MarketThe global Skin Cancer Drugs Market is estimated to be valued at US$ 8 Bn or Billion in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Skin cancer drugs are used for treating the most common types of skin cancer called basal cell carcinoma (BCC) and squamous cell...0 Comentários 0 Compartilhamentos 1538 Visualizações 0 Anterior